Results 121 to 130 of about 8,686 (179)

Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs. [PDF]

Future Oncol
Yu EY, Gratzke C, Burotto M, Zhang AY, Lévesque E, Ortega F, Peer A, Vile D, Chen ZH, Song Y, Schloss C, Todoric J, Garratt C, Poehlein C, Antonarakis ES, Fizazi K.   +15 more
europepmc   +1 more source

Fludrocortisone to treat patients with aneurysmal subarachnoid haemorrhage: Protocol for an international, phase 3, randomised, placebo-controlled, multicentre trial. [PDF]

Crit Care Resusc
Cohen J, Delaney A, Udy A, Andersen C, Anderson CS, Bellapart J, Burrell LM, Devaux A, Evans DM, Fitzgerald E, Garside T, Hammond N, Hardie M, Jeffree RL, Knowles S, Lassig-Smith M, Li Q, Nethathe G, Rajbhandari D, Ramanan M, Talbot P, Taylor C, Wright J, Young MJ, Young PJ, Venkatesh B.   +25 more
europepmc   +1 more source

Management of Primary Adrenal Insufficiency and Overt Hypothyroidism in an HIV-Positive Patient in a Resource-Limited Setting: A Case Report. [PDF]

Clin Case Rep
Edward M, John W, Raphael DM.
europepmc   +1 more source

Cardiovascular risk profile of low-dose prednisolone and its effect on the quality of life in patients with adrenal insufficiency: the HYPER-AID observational study. [PDF]

Endocr Connect
Ssemmondo E, Lazarus K, Newham M, Narula K, Htut Z, Sathyapalan T, Choudhury S, Meeran K.   +7 more
europepmc   +1 more source

A Polyendocrine Puzzle: Unravelling Schmidt Syndrome (Autoimmune Polyendocrine Syndrome Type II) Presenting in Crisis. [PDF]

Cureus
Rahman SS, Chowdhury NA, Poonthottam N, Kamal S, Sarwar MA.   +4 more
europepmc   +1 more source